期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
International Alliance of Urolithiasis(IAU)consensus on miniaturized percutaneous nephrolithotomy
1
作者 Guo-Hua Zeng Wen Zhong +61 位作者 Giorgio Mazzon Wei Zhu Sven Lahme Sanjay Khadgi Janak Desai Madhu Agrawal David Schulsinger Mantu Gupta Emanuele Montanari Juan Manuel Lopez Martinez Shabir Almousawi Vincent Emanuel FMalonzo Seshadri Sriprasad Otas Durutovic Vimoshan Arumuham Stefania Ferretti Wissam Kamal Ke-Wei Xu Fan Cheng Xiao-Feng Gao Ji-Wen Cheng Bhaskar Somani Mordechai Duvdevani Kah Ann Git Christian Seitz Norberto Bernardo Tarek Ahmed Amin Ibrahim Albert Aquino takahiro yasui Cristian Fiori Thomas Knoll Athanasios Papatsoris Nariman Gadzhiev Ulanbek Zhanbyrbekuly Oriol Angerri Hugo Lopez Ramos Iliya Saltirov Mohamad Moussa Guido Giusti Fabio Vicentini Edgar Beltran Suarez Margaret Pearle Glenn MPreminger Qing-Hui Wu Chu Ann Chai Khurshid Ghani Marcus Maroccolo Marianne Brehmer Palle JOsther Marek Zawadzki Azimdjon Tursunkulov Monolov Nurbek Kytaibekovich Abdusamad Abdukakhorovich Abuvohidov Cesar Antonio Recalde Lara Zamari Noori Stefano Paolo Zanetti Sunil Shrestha Jean de la Rosette John Denstedt Zhang-Qun Ye Kemal Sarica Simon Choong 《Military Medical Research》 2025年第7期985-995,共11页
Over the past three decades,there has been increasing interest in miniaturized percutaneous nephrolithotomy(mPCNL)techniques featuring smaller tracts as they offer potential solutions to mitigate complications associa... Over the past three decades,there has been increasing interest in miniaturized percutaneous nephrolithotomy(mPCNL)techniques featuring smaller tracts as they offer potential solutions to mitigate complications associated with standard PCNL(sPCNL).However,despite this growing acceptance and recognition of its benefits,unresolved controversies and acknowledged limitations continue to impede widespread adoption due to a lack of consensus on optimal perioperative management strategies and procedural tips and tricks.In response to these challenges,an international panel comprising experts from the International Alliance of Urolithiasis(IAU)took on the task of compiling an expert consensus document on mPCNL procedures aimed at providing urologists with a comprehensive clinical framework for practice.This endeavor involved conducting a systematic literature review to identify research gaps(RGs),which formed the foundation for developing a structured questionnaire survey.Subsequently,a two-round modified Delphi survey was implemented,culminating in a group meeting to generate final evidence-based comments.All 64 experts completed the second-round survey,resulting in a response rate of 100.0%.Fifty-eight key questions were raised focusing on mPCNLs within 4 main domains,including general information(13 questions),preoperative work-up(13 questions),procedural tips and tricks(19 questions),and postoperative evaluation and follow-up(13 questions).Additionally,9 questions evaluated the experts’experience with PCNLs.Consensus was reached on 30 questions after the second-round survey,while professional statements for the remaining 28 key questions were provided after discussion in an online panel meeting.mPCNL,characterized by a tract smaller than 18 Fr and an innovative lithotripsy technique,has firmly established itself as a viable and effective approach for managing upper urinary tract stones in both adults and pediatrics.It offers several advantages over sPCNL including reduced bleeding,fewer requirements for nephrostomy tubes,decreased pain,and shorter hospital stays.The series of detailed techniques presented here serve as a comprehensive guide for urologists,aiming to improve their procedural understanding and optimize patient outcomes. 展开更多
关键词 Percutaneous nephrolithotomy(PCNL) Miniaturized PCNL(mPCNL) Expert consensus Kidney stone Operation
原文传递
RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma 被引量:2
2
作者 DAWEI ZHU LEI ZHANG +10 位作者 XIAOKAI SHI SHENGLIN GAO CHUANG YUE LIFENG ZHANG YU BAI QIFENG WANG ATSUSHI OKADA takahiro yasui CHAO WANG XINGANG CUI LI ZUO 《Oncology Research》 SCIE 2021年第3期159-174,共16页
Identifying prognostic indicators of clear cell renal cell carcinoma(ccRCC)and elucidating the mechanisms underlying ccRCC progression are crucial for improving ccRCC patient prognosis.This study investigated the clin... Identifying prognostic indicators of clear cell renal cell carcinoma(ccRCC)and elucidating the mechanisms underlying ccRCC progression are crucial for improving ccRCC patient prognosis.This study investigated the clinical significance and biological role of Ring finger protein 43(RNF43)in ccRCC.Two independent cohorts of patients with ccRCC were employed to determine the prognostic significance of RNF43 by immunohistochemistry and statistical analyses.In vitro and in vivo experiments,RNA-seq,and other techniques were used to determine the biological role of RNF43 in ccRCC and related molecular mechanisms.RNF43 expression was commonly decreased in ccRCC specimens,and low expression of RNF43 indicated a higher TNM stage,SSIGN score,and WHO/ISUP grade and short survival in patients with ccRCC.Additionally,RNF43 overexpression suppressed the proliferation,migration,and targeted drug resistance of ccRCC cells,while the knockdown of RNF43 enhanced these characteristics of ccRCC.RNF43 knockdown activated YAP signaling by decreasing YAP phosphorylation by p-LATS1/2 and increasing the transcription and nuclear distribution of YAP.By contrast,RNF43 overexpression showed the opposite effects.Decreasing YAP abolished the effect of RNF43 knockdown in promoting the malignant features of ccRCC.Additionally,restoring RNF43 expression suppressed the resistance of the targeted drug pazopanib in in vivo orthotopic ccRCC.Furthermore,combining the expression of RNF43 and YAP with TNM stage or the SSIGN score exhibited greater accuracy than any of these indicators alone in assessing the postoperative prognosis of ccRCC patients.In summary,our study identified a novel tumor suppressor,RNF43,which is also a prognostic indicator and potential target for ccRCC. 展开更多
关键词 Clear cell renal cell carcinoma RNF43 PROGNOSIS YAP Tumor progression
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部